original ) (raw )Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection
Julia Toscano
Human Papillomavirus and Related Diseases - From Bench to Bedside - Research aspects, 2012
View PDFchevron_right
5 Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection
Julia Toscano
2012
View PDFchevron_right
In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: potential treatment for genital warts
Maureen Fox
Antimicrobial Agents and Chemotherapy, 1993
View PDFchevron_right
In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical Carcinoma
Marilu Madrigal , Mike Janicek
Gynecologic Oncology, 1997
View PDFchevron_right
Inhibition of Human Papillomavirus Expression Using DNAzymes
Pablo Reyes-Gutierrez
Methods in Molecular Biology, 2011
View PDFchevron_right
The development and future of oligonucleotide-based therapies for cervical cancer
Aaron T Irving
Current opinion in molecular therapeutics, 2007
View PDFchevron_right
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
영준 신
Journal of clinical medicine, 2015
View PDFchevron_right
A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions
Thomas Broker
Cell Cycle, 2009
View PDFchevron_right
Targeting human papillomavirus genome replication for antiviral drug discovery
Thomas Melendy
Antiviral Therapy, 2013
View PDFchevron_right
Current Perspectives in Human Papillomavirus [Working Title]
SubbaRao Madhunapantula
Current Perspectives in Human Papillomavirus, 2018
View PDFchevron_right
Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter
Yukai He
Cancer research, 1997
View PDFchevron_right
Anti-human papillomavirus therapeutics: facts & future
Alok Chandra Bharti
The Indian journal of medical research, 2009
View PDFchevron_right
A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity
Manuela Donalisio
The FASEB Journal, 2005
View PDFchevron_right
Future of RNAi-based therapies for human papillomavirus-associated cervical cancer
Aaron T Irving
Future Virology, 2007
View PDFchevron_right
Editorial - ONCOGENIC HUMAN PAPILLOMAVIRUSES - High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-Escape
Angel Cid-Arregui
The Open Virology Journal, 2012
View PDFchevron_right
Human Papilloma Virus: Biomolecular Aspect
Rizal sanif
2021
View PDFchevron_right
Novel recombinant papillomavirus genomes expressing selectable genes
Wesley H Stepp
View PDFchevron_right
Papillomavirus: Viral vectors in the gene therapy and new therapeutic targets
Ortrud Barth
International Journal of Biomedical Research, 2015
View PDFchevron_right
Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs
Pascale Reverdiau
Molecular Cancer Therapeutics, 2009
View PDFchevron_right
Development of a Cellular Assay System To Study the Genome Replication of High- and Low-Risk Mucosal and Cutaneous Human Papillomaviruses
Jelizaveta Geimanen
Journal of Virology, 2011
View PDFchevron_right
A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms
Hugo Barrera-saldaña
The Journal of Gene Medicine, 2007
View PDFchevron_right
HPV episome levels are potently decreased by pyrrole–imidazole polyamides
James Bashkin
Antiviral Research, 2011
View PDFchevron_right
A Phase II Study: Efficacy of the Gene Therapy of the MVA E2 Recombinant Virus in the Treatment of Precancerous Lesions (NIC I and NIC II) Associated with Infection of Oncogenic Human Papillomavirus
Alberto Calderón tinoco
Human Gene Therapy, 2002
View PDFchevron_right
Synthetic oligonucleotide probes for the detection of human papilloma viruses by in situ hybridisation
Heather Cubie
Journal of Virological Methods, 1988
View PDFchevron_right
Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis
SAMIRA ZOA ASSOUMOU
Frontiers in Bioscience-Landmark
View PDFchevron_right
HUMAN PAPILLOMAVIRUS BIOLOGY: REVIEW
vikrant sangar , Abhay Chowdhary
Journal of Advanced Research
View PDFchevron_right
Cellular transformation by human papillomavirus DNA in vitro
Anthony Faras
Science, 1984
View PDFchevron_right
Developing Michigan Cancer Foundation 7 Cells with Stable Expression of E7 Gene of Human Papillomavirus Type 16
Maryam Sadat nabavinia
Iranian journal of pathology, 2016
View PDFchevron_right
Human Papillomavirus Genotyping by Dual Priming Oligonucleotide Technology And Its Clinical Efficacy in Cervical Cancer Management
DR. NAROTAM SHARMA
Microbiology
View PDFchevron_right
Detection of human papillomavirus DNA and mRNA using synthetic, type-specific oligonucleotide probes
Anthony Borg
Journal of Virological Methods, 1993
View PDFchevron_right